These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24603416)

  • 1. Antiphospholipid antibody-associated choroidopathy.
    Silva RA; Moshfeghi DM
    Eye (Lond); 2014 Jun; 28(6):773-4. PubMed ID: 24603416
    [No Abstract]   [Full Text] [Related]  

  • 2. Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome.
    Klemm P; Müller-Ladner U; Tarner IH; Lange U; Hudowenz O
    Autoimmun Rev; 2020 Aug; 19(8):102594. PubMed ID: 32535091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Choroidal neovascularisation in a patient with punctate inner choroidopathy (PIC)].
    Mayer C; Khoramnia R
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):915-7. PubMed ID: 21437845
    [No Abstract]   [Full Text] [Related]  

  • 4. Chorioretinopathy in primary antiphospholipid syndrome: a case report.
    Boets EP; Chaar CG; Ronday K; Keunen JE; Breedveld FC
    Retina; 1998; 18(4):382-5. PubMed ID: 9730188
    [No Abstract]   [Full Text] [Related]  

  • 5. Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome.
    Ruffatti A; Tonello M; Macor P; Calligaro A; Del Ross T; Favaro M; Lotti V; Carletto A; Hoxha A; Biasi D
    Blood; 2021 May; 137(21):2989-2992. PubMed ID: 33649771
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiphospholipid antibody syndrome mimicking serpiginous choroidopathy.
    Tang J; Fillmore G; Nussenblatt RB
    Ocul Immunol Inflamm; 2009; 17(4):278-81. PubMed ID: 19657983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab.
    Yelnik CM; Miranda S; Mékinian A; Lazaro E; Quéméneur T; Provot F; Frimat M; Morell-Dubois S; Le Guern V; Hachulla E; Costedoat-Chalumeau N; Lambert M
    Blood; 2020 Nov; 136(21):2473-2477. PubMed ID: 32722806
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary antiphospholipid syndrome presented as thrombotic microangiopathy in renal transplantation.
    Bada-Bosch T; Redondo B; Sevillano AM; Alonso M; Trujillo H; Auñón P; Polanco N; Rodríguez L; Gonzalez E; Andrés A
    Nefrologia (Engl Ed); 2020; 40(1):108-110. PubMed ID: 31431303
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle.
    Barnini T; Silvestri E; Emmi G; D'Elios MM; Beccastrini E; Squatrito D; Emmi L; Prisco D
    Clin Exp Rheumatol; 2012; 30(5):806. PubMed ID: 22992328
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiphospholipid antibodies.
    Houghton DE; Moll S
    Vasc Med; 2017 Dec; 22(6):545-550. PubMed ID: 29103369
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.
    Erkan D; Salmon JE
    Turk J Haematol; 2016 Mar; 33(1):1-7. PubMed ID: 27020721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eculizumab and renal transplantation in a patient with CAPS.
    Lonze BE; Singer AL; Montgomery RA
    N Engl J Med; 2010 May; 362(18):1744-5. PubMed ID: 20445191
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural course of symptomatic focal choroidal excavation.
    Pierro L; Casalino G; Introini U; Gagliardi M; Sergenti J; Cascavilla ML; Bandello F
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):125-30. PubMed ID: 25559525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance of a strong triple positivity for antiphospholipid antibodies after treatment with anakinra.
    Arnaud E; Soulier C; Gris JC
    Haematologica; 2019 Feb; 104(2):e83-e84. PubMed ID: 30361417
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiphospholipid antibodies and the antiphospholipid syndrome II: limitations, standardization, and clinical utility of laboratory testing.
    Favaloro EJ; Wong RC
    Semin Thromb Hemost; 2008 Jun; 34(4):309-12. PubMed ID: 18814063
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.
    Bećarević M
    Curr Rheumatol Rep; 2017 Jul; 19(7):40. PubMed ID: 28631067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Takayasu arteritis and antiphospholipid antibody syndrome in an elderly woman.
    Lee HJ; Hwang JP; Kim HS
    Korean J Intern Med; 2015 Nov; 30(6):934-7. PubMed ID: 26552473
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral cilioretinal artery occlusion in antiphospholipid syndrome.
    Carrero JL; Sanjurjo FJ
    Retina; 2006 Jan; 26(1):104-6. PubMed ID: 16395148
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.
    Oulego-Erroz I; Martínez-Sáenz de Jubera J; Ocaña-Alcober C; Regueras-Santos L; Ferrero-De la Mano L; Martínez-Badás JP
    Am J Respir Crit Care Med; 2021 Mar; 203(5):640-642. PubMed ID: 33142067
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rituximab action on the antiphospholipid antibodies in patients with thrombotic antiphospholipid syndrome].
    Peiró P; Prieto-González S; de la Red G; Espinosa G
    Med Clin (Barc); 2016 Jun; 146(12):e69-70. PubMed ID: 26961401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.